Literature DB >> 1833815

Greater trochanteric pain syndrome (trochanteric bursitis) in low back pain.

G Collée1, B A Dijkmans, J P Vandenbroucke, A Cats.   

Abstract

The greater trochanteric pain syndrome (GTPS) or trochanteric bursitis is a regional pain syndrome characterized by typical local tenderness over the trochanteric region. Recently this syndrome was found in hospital-referred, chronic low back pain (LBP) patients. To confirm the correlation between GTPS and LBP in different patient settings and to present quantitative data about associated clinical features, we prospectively evaluated consecutive LBP patients from a general practice (n = 40), an occupational health service (n = 124) and a rheumatology outpatient clinic (n = 40). GTPS was found in 25, 18 and 45% of patients, respectively and was associated with female sex and duration of LBP. Associated clinical features were radiating pain and paraesthesiae in the legs, tenderness of the ilio-tibial tract and aggravation of pain during standing for a short time, descending stairs, lying on the affected side and crossing legs. These observations demonstrate that GTPS is common in LBP and is easy to recognize on clinical grounds.

Entities:  

Mesh:

Year:  1991        PMID: 1833815     DOI: 10.3109/03009749109096798

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  14 in total

1.  Early results of endoscopic trochanter bursectomy.

Authors:  Matthias Wiese; Frank Rubenthaler; Roland Ernst Willburger; Sabine Fennes; Rolf Haaker
Journal:  Int Orthop       Date:  2004-06-09       Impact factor: 3.075

2.  Surgery for greater trochanteric pain syndrome after total hip replacement confers a poor outcome.

Authors:  Eve Robertson-Waters; James R Berstock; Michael R Whitehouse; Ashley W Blom
Journal:  Int Orthop       Date:  2017-07-28       Impact factor: 3.075

3.  Prognosis of trochanteric pain in primary care.

Authors:  Annet Lievense; Sita Bierma-Zeinstra; Boris Schouten; Arthur Bohnen; Jan Verhaar; Bart Koes
Journal:  Br J Gen Pract       Date:  2005-03       Impact factor: 5.386

Review 4.  Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management.

Authors:  Alison Grimaldi; Rebecca Mellor; Paul Hodges; Kim Bennell; Henry Wajswelner; Bill Vicenzino
Journal:  Sports Med       Date:  2015-08       Impact factor: 11.136

5.  Corticosteroid injections for greater trochanteric pain syndrome: a randomized controlled trial in primary care.

Authors:  Aaltien Brinks; Rogier M van Rijn; Sten P Willemsen; Arthur M Bohnen; Jan A N Verhaar; Bart W Koes; Sita M A Bierma-Zeinstra
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

6.  Great trochanter bursitis vs sciatica, a diagnostic-anatomic trap: differential diagnosis and brief review of the literature.

Authors:  Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis
Journal:  Eur Spine J       Date:  2018-02-01       Impact factor: 3.134

Review 7.  The management of greater trochanteric pain syndrome: A systematic literature review.

Authors:  Diane Reid
Journal:  J Orthop       Date:  2016-01-22

8.  Spinopelvic parameters in greater trochanteric pain syndrome: a retrospective case-control study.

Authors:  Robin Canetti; Benoit de Saint Vincent; Thais D Vieira; Vincent Fière; Mathieu Thaunat
Journal:  Skeletal Radiol       Date:  2019-12-11       Impact factor: 2.199

Review 9.  Retro-trochanteric sciatica-like pain: current concept.

Authors:  Khaled Meknas; Oddmund Johansen; Jüri Kartus
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-06-16       Impact factor: 4.342

10.  Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice.

Authors:  Aaltien Brinks; Rogier M van Rijn; Arthur M Bohnen; Gabriël L J Slee; Jan A N Verhaar; Bart W Koes; Sita M A Bierma-Zeinstra
Journal:  BMC Musculoskelet Disord       Date:  2007-09-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.